HomeAKBA • NASDAQ
add
Akebia Therapeutics Inc
Previous close
$1.34
Day range
$1.34 - $1.35
Year range
$0.78 - $2.48
Market cap
283.72M USD
Avg Volume
1.20M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | 43.65M | -22.58% |
Operating expense | 43.58M | -22.53% |
Net income | -8.58M | 23.18% |
Net profit margin | -19.66 | 0.81% |
Earnings per share | -0.04 | 33.67% |
EBITDA | 685.00K | 116.09% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 39.50M | -26.27% |
Total assets | 220.20M | -13.21% |
Total liabilities | 253.95M | -9.47% |
Total equity | -33.75M | — |
Shares outstanding | 210.29M | — |
Price to book | -8.38 | — |
Return on assets | -9.79% | — |
Return on capital | -30.73% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -8.58M | 23.18% |
Cash from operations | -10.07M | -377.38% |
Cash from investing | -29.00K | — |
Cash from financing | 7.64M | 195.50% |
Net change in cash | -2.46M | 43.83% |
Free cash flow | 43.73M | 196.99% |
About
Founded
Jan 1, 2007
Headquarters
Website
Employees
167